Pharmaceuticals

Peptide Antibiotics Market Forecast Through 2030 With Insights On Market Patterns And Developments

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Peptide Antibiotics Market From 2026 To 2030?

The peptide antibiotics market size has shown robust growth in recent years. It is projected to expand from $5.77 billion in 2025 to $6.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. The expansion observed during the historic period stemmed from factors such as the rise of antibiotic-resistant bacterial strains, increased hospital-acquired infection rates, advancements in peptide synthesis technologies, growing clinical research in infectious diseases, and government funding for antibiotic R&D.

The peptide antibiotics market size is projected to experience robust expansion over the coming years. This market is predicted to reach $9.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. The anticipated growth during this period stems from factors such as the increasing occurrence of multi-drug resistant infections, the widening global healthcare infrastructure, innovations in peptide delivery technologies, growing partnerships with CDMOs, and the increasing recognition and application of precision medicine strategies. Key trends expected in the forecast period involve a surging need for solutions addressing multi-drug resistant (MDR) infections, the broader application of peptide antibiotics in treating hospital-acquired infections, an increase in contract manufacturing and CDMO partnerships, the growing embrace of personalized and targeted antibiotic treatments, and an emphasis on developing peptide antibiotics that offer reduced toxicity and fewer side effects.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Significant Factors Are Influencing The Peptide Antibiotics Market Expansion?

The Peptide Antibiotics Market is projected to see growth driven by the rising occurrence of various infectious diseases. Infectious diseases are conditions caused by harmful microorganisms such as bacteria, fungi, and parasites. Key contributors to the increase in these diseases include rapid urbanization, climate change, and a heightened risk of new disease emergence, all of which have boosted the demand for peptide antibiotics. These antibiotics work by physically rupturing cell membranes, forming the basis of their antibacterial activity. For instance, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, noted that dengue cases in the America region had already surpassed seven million by April 2024, a figure significantly higher than the 4.6 million cases reported in all of 2023. This escalating incidence of infectious diseases is thus a primary force propelling the growth of the Peptide Antibiotics Market.

How Is The Peptide Antibiotics Market Broken Down By Segment Categories?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

What Trends Are Shaping The Future Of The Peptide Antibiotics Market?

Leading companies in the peptide antibiotics market are introducing generic alternatives to offer patients more accessible options. These generic peptide antibiotics are economical, off-patent substitutes for branded peptide-based antibiotics, employed in the treatment of various bacterial infections. For example, in July 2023, Camber Pharmaceuticals, a US-based pharmaceutical firm, expanded its product range by launching a generic variant of Daptomycin for Injection. Daptomycin for Injection is a peptide antibiotic, specifically a cyclic lipopeptide antibiotic synthesized by non-ribosomal machinery. This generic variant is available in 350 mg and 500 mg strengths and is indicated for the management of complicated skin and skin structure infections (cSSSI) in adults and pediatric patients aged 1 to 17 years.

Which Players Are Present In The Peptide Antibiotics Market Space?

Major companies operating in the peptide antibiotics market are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Basilea Pharmaceutica Ltd.

Get The Full Peptide Antibiotics Market Report:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Which Region Accounts For The Largest Portion Of The Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2025. The regions covered in the peptide antibiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Peptide Antibiotics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Browse Through More Reports Similar to the Global Peptide Antibiotics Market 2026, By The Business Research Company

Peptide Antibiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Antibiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795